Matrix metalloproteinase inhibition prevents oxidative stress-associated blood-brain barrier disruption after transient focal cerebral ischemia.
about
Therapy Effects of Bone Marrow Stromal Cells on Ischemic StrokeOxidative DNA Damage Mediated by Intranuclear MMP Activity Is Associated with Neuronal Apoptosis in Ischemic StrokeImplications of MMP9 for Blood Brain Barrier Disruption and Hemorrhagic Transformation Following Ischemic StrokeAstaxanthin as a Potential Neuroprotective Agent for Neurological DiseasesRole of Oxidative Stress in HIV-1-Associated Neurocognitive Disorder and Protection by Gene Delivery of Antioxidant EnzymesRational modulation of the innate immune system for neuroprotection in ischemic strokeFetal stress and programming of hypoxic/ischemic-sensitive phenotype in the neonatal brain: mechanisms and possible interventionsMethylophiopogonanone A Protects against Cerebral Ischemia/Reperfusion Injury and Attenuates Blood-Brain Barrier Disruption In VitroMorroniside improves microvascular functional integrity of the neurovascular unit after cerebral ischemiaEffect of chronic alcohol consumption on brain damage following transient focal ischemiaCortical spreading depression activates and upregulates MMP-9.Molecular insights and therapeutic targets for blood-brain barrier disruption in ischemic stroke: critical role of matrix metalloproteinases and tissue-type plasminogen activatorHemostasis and alterations of the central nervous systemSpontaneous intracerebral hemorrhage during acute and chronic hypertension in mice.Matrix metalloproteinase-9 mediates hypoxia-induced vascular leakage in the brain via tight junction rearrangement.Peroxynitrite decomposition catalyst prevents matrix metalloproteinase activation and neurovascular injury after prolonged cerebral ischemia in rats.Molecular mechanisms underlying the effects of statins in the central nervous system.Oxidative stress in ischemic brain damage: mechanisms of cell death and potential molecular targets for neuroprotectionRole of superoxide dismutases in oxidative damage and neurodegenerative disorders.Matrix metalloproteinase inhibitors attenuate neuroinflammation following focal cerebral ischemia in mice.Blood-brain barrier dysfunction in disorders of the developing brainCan polyclonal intravenous immunoglobulin limit cytokine mediated cerebral damage and chronic lung disease in preterm infants?Effect of polyphenols on oxidative stress and mitochondrial dysfunction in neuronal death and brain edema in cerebral ischemia.Disruption in the Blood-Brain Barrier: The Missing Link between Brain and Body Inflammation in Bipolar Disorder?Influence of hyperglycemia on oxidative stress and matrix metalloproteinase-9 activation after focal cerebral ischemia/reperfusion in rats: relation to blood-brain barrier dysfunctionCB2 receptor activation attenuates microcirculatory dysfunction during cerebral ischemic/reperfusion injury.Intranuclear matrix metalloproteinases promote DNA damage and apoptosis induced by oxygen-glucose deprivation in neurons.Extracellular proteolytic pathophysiology in the neurovascular unit after stroke.Vascular aspects of neuroprotection.AM-36 modulates the neutrophil inflammatory response and reduces breakdown of the blood brain barrier after endothelin-1 induced focal brain ischaemia.Critical role of sphingosine-1-phosphate receptor-2 in the disruption of cerebrovascular integrity in experimental strokeTargeting neutrophils in ischemic stroke: translational insights from experimental studies.Contribution of thrombin-reactive brain pericytes to blood-brain barrier dysfunction in an in vivo mouse model of obesity-associated diabetes and an in vitro rat modelHIV-1 gp120-induced injury to the blood-brain barrier: role of metalloproteinases 2 and 9 and relationship to oxidative stressTWEAK/Fn14 pathway modulates properties of a human microvascular endothelial cell model of blood brain barrier.Induction of mmp-9 expression and endothelial injury by oxidative stress after spinal cord injuryDiverse roles of matrix metalloproteinases and tissue inhibitors of metalloproteinases in neuroinflammation and cerebral ischemia.Matrix metalloproteinases and blood-brain barrier disruption in acute ischemic stroke.Multiple expression of matrix metalloproteinases in murine neurocysticercosis: Implications for leukocyte migration through multiple central nervous system barriers.The role of dietary antioxidant insufficiency on the permeability of the blood-brain barrier.
P2860
Q26749052-BAE2E5F9-C092-4139-9A81-9C6CE7CB112FQ26765807-269EFA18-790D-447B-9ECA-DD6264B89688Q26766038-E1112AF0-ECF7-4C23-907F-326392299D8AQ26785969-2CEF4093-8CF2-4940-89F0-E92970A39CC2Q26829535-31DAC689-25B9-498D-A21A-D1B2550B2CC1Q26851831-136FF7CD-C6B7-45DE-B997-047CF6D2A83FQ26996467-CD743002-D1DE-4EB8-9ECE-17CA42FDEC98Q27309034-038AD6EE-F7A6-4306-8D88-1DAC425EC330Q28540191-29001C30-3B57-48B9-86F3-2D039C721399Q33314497-D2C226D6-F1C0-4C05-BE05-3DE47BB3EB4DQ33785624-01C0E77B-6177-4B4E-9109-075DC4D0FBAEQ33823616-A87329AA-DCD0-4F7C-B903-02F93B8F42D8Q33842161-9BBB8A5A-E81D-492A-B2B1-A76E7A1D4CCEQ33922782-9048EF08-00CC-4D35-97D5-CC5132D2CEE2Q34170971-00621247-F88F-4C9A-8FED-847C05702958Q34281028-8187BC97-6CA9-40AF-8231-75AFD3CC3569Q34685463-814646CF-A4AE-4145-9EEF-F3D7EF1916C5Q34700207-E75497E8-2662-4542-9ED1-76061C691618Q34795518-F9FFA0E2-F8E3-4D69-BE2C-527A26B15ED5Q35014025-0C2FE6B6-CC6C-4E5B-B825-CA81BF76E71FQ35090124-E349B315-5C2B-4B3D-8A8E-E3BC09981A49Q35294158-2E1BD396-60F5-49CB-987E-21603D997C6BQ35600243-E98EF06D-826E-4824-A06B-0D219E36670CQ35649716-642975E4-E901-4B9A-AD1E-F3C951917DFBQ35688394-F7243E0A-9E23-4875-83CA-0E876139D9CDQ35870490-7E75A169-F908-4700-A6B6-6B04AE364E6DQ35987121-CF8469C5-D7CF-43D9-A3C4-4FC12152A7A1Q36052713-BA0D314C-D731-42B3-8AF4-990D11499D88Q36052719-4EB67A07-E0E4-40A8-BA3D-BE30F43ADD4FQ36054388-3D3E68D0-B689-4649-AFC0-25661E4E3F8CQ36104426-928A56EC-5233-4265-8B94-65184BC8AE4FQ36267227-39054A3B-33F7-4806-98E6-997BC1022FAFQ36368063-A6151455-0388-4B52-9B91-C0149131E06CQ36450103-4648010E-6C13-451A-9840-A183D95E0936Q36604118-F0C72FCF-B973-455C-AAA7-D05B49ADE2A7Q36627288-8CE6E53E-CC7D-4697-9F6A-3596E7894989Q36644315-EA351E45-5DD0-442F-9E04-92E72F8CCFC3Q36736442-0A6D6570-BBFE-464F-905E-EEF59AE05D75Q36839585-BD0993EA-A7F1-4C89-A6B5-51CD6936EBC6Q36898119-40F99C87-0C37-4373-AB9F-EEB1B8F71E70
P2860
Matrix metalloproteinase inhibition prevents oxidative stress-associated blood-brain barrier disruption after transient focal cerebral ischemia.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
Matrix metalloproteinase inhib ...... sient focal cerebral ischemia.
@en
type
label
Matrix metalloproteinase inhib ...... sient focal cerebral ischemia.
@en
prefLabel
Matrix metalloproteinase inhib ...... sient focal cerebral ischemia.
@en
P2093
P2860
P1476
Matrix metalloproteinase inhib ...... sient focal cerebral ischemia.
@en
P2093
P2860
P304
P356
10.1097/00004647-200112000-00003
P577
2001-12-01T00:00:00Z
P5875
P6179
1037734760